Home » Authors » Douglas Merrill

Articles by Douglas Merrill

German Parliamentarians Press For Research-Friendly Changes

July 30, 2003

By Douglas Merrill

Therascope Raises EUR24.1 To Fund New Discovery Approach

July 23, 2003

By Douglas Merrill

Intercell Raises EUR30M In Third Round To Fund Vaccines Work

July 23, 2003

By Douglas Merrill

Intercell Raises EUR30M In Third Round To Fund Vaccines Work

July 23, 2003

By Douglas Merrill

Therascope Raises EUR24.1 To Fund New Discovery Approach

July 23, 2003

By Douglas Merrill

Igeneon Presents Antibody Data, Keeps Eye Out For IPO Window

July 16, 2003

By Douglas Merrill

Igeneon Presents Antibody Data, Keeps Eye Out For IPO Window

July 16, 2003

By Douglas Merrill

Ribopharma, Alnylam Merge RNAi Programs, Gain Financing

July 9, 2003

By Douglas Merrill

Ribopharma, Alnylam Merge RNAi Programs, Gain Financing

July 9, 2003

By Douglas Merrill

Wilex Begins Clinical Testing Of Product For Biliary Cancers

July 2, 2003

By Douglas Merrill

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...